{"id":"https://openalex.org/W7225745087","doi":"https://doi.org/10.25251/hwgx7622","title":"Bimekizumab efficacy & safety versus risankizumab to 24 weeks in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis: An exploratory analysis of the BE BOLD study","display_name":"Bimekizumab efficacy & safety versus risankizumab to 24 weeks in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis: An exploratory analysis of the BE BOLD study","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225745087","doi":"https://doi.org/10.25251/hwgx7622"},"language":"en","primary_location":{"id":"doi:10.25251/hwgx7622","doi":"https://doi.org/10.25251/hwgx7622","is_oa":true,"landing_page_url":"https://doi.org/10.25251/hwgx7622","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25251/hwgx7622","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5124940473","display_name":"Richard G. Langley","orcid":"https://orcid.org/0000-0003-4730-2164","observed_orcids":["https://orcid.org/0000-0003-4730-2164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard G. Langley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049859852","display_name":"Alice Bendix Gottlieb","orcid":"https://orcid.org/0000-0002-2927-8618","observed_orcids":["https://orcid.org/0000-0002-2927-8618"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice B. Gottlieb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112094786","display_name":"Mark G. Lebwohl","orcid":"https://orcid.org/0000-0002-4705-5303","observed_orcids":["https://orcid.org/0000-0002-4705-5303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Lebwohl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161365003","display_name":"E. James Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. James Song","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085831636","display_name":"Diamant Tha\u00e7i","orcid":"https://orcid.org/0000-0001-8513-550X","observed_orcids":["https://orcid.org/0000-0001-8513-550X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diamant Tha\u00e7i","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138808095","display_name":"Akimichi Morita","orcid":"https://orcid.org/0000-0001-8372-3754","observed_orcids":["https://orcid.org/0000-0001-8372-3754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akimichi Morita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159001216","display_name":"Philip J. Mease","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip J. Mease","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071482630","display_name":"Iain B. McInnes","orcid":"https://orcid.org/0000-0002-6462-4280","observed_orcids":["https://orcid.org/0000-0002-6462-4280","https://orcid.org/0000-0003-4449-8501"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iain B. McInnes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091895459","display_name":"Laure Gossec","orcid":"https://orcid.org/0000-0002-4528-310X","observed_orcids":["https://orcid.org/0000-0002-4528-310X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laure Gossec","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161398068","display_name":"Yoshiya Tanaka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshiya Tanaka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011476143","display_name":"Barbara S. Ink","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Ink","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022299146","display_name":"Alexander Marten","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Marten","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037183472","display_name":"Jason Coarse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Coarse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044071423","display_name":"Myriam Manente","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myriam Manente","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043452005","display_name":"Balint Szilagyi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Balint Szilagyi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047076464","display_name":"Joseph Frank Merola","orcid":"https://orcid.org/0000-0001-6514-4353","observed_orcids":["https://orcid.org/0000-0001-6514-4353"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph F. Merola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"s814","last_page":"s814"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.012199999764561653,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9323999881744385},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.843999981880188},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.8165000081062317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6722999811172485},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6140999794006348},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.5672000050544739},{"id":"https://openalex.org/C3018260909","wikidata":"https://www.wikidata.org/wiki/Q1322871","display_name":"Exploratory analysis","level":2,"score":0.5512999892234802},{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.4603999853134155},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4602000117301941},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3765999972820282},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32190001010894775},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3165000081062317},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.3140000104904175},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.31279999017715454},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2994999885559082},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.28949999809265137},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.26980000734329224},{"id":"https://openalex.org/C202953159","wikidata":"https://www.wikidata.org/wiki/Q382695","display_name":"Intention-to-treat analysis","level":3,"score":0.26019999384880066},{"id":"https://openalex.org/C2776821229","wikidata":"https://www.wikidata.org/wiki/Q16965166","display_name":"Inflammatory arthritis","level":3,"score":0.2547999918460846}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/hwgx7622","doi":"https://doi.org/10.25251/hwgx7622","is_oa":true,"landing_page_url":"https://doi.org/10.25251/hwgx7622","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/hwgx7622","doi":"https://doi.org/10.25251/hwgx7622","is_oa":true,"landing_page_url":"https://doi.org/10.25251/hwgx7622","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W4317936387"],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"In":[1,311,366],"patients":[2],"(pts)":[3],"with":[4,38,55,71,88,109,125,151,201,313,323,342,375],"psoriatic":[5],"arthritis":[6],"(PsA)":[7],"in":[8,29,86,106,123,143,149,262,277],"the":[9,20,326],"BE":[10,97],"BOLD":[11,98],"study,":[12],"bimekizumab":[13],"(BKZ;":[14],"IL-17A/F":[15,322],"inhibitor)":[16,42],"reported":[17,165,276],"superiority":[18],"for":[19,381],"joint-focused":[21],"primary":[22],"endpoint":[23],"(\u226550%":[24],"improvement":[25],"from":[26],"baseline":[27],"[BL]":[28],"American":[30],"College":[31],"of":[32,82,174,184,199,230,321,334,361],"Rheumatology":[33],"response":[34,265],"criteria":[35],"[ACR50])":[36],"compared":[37],"risankizumab":[39],"(RZB;":[40],"IL-23":[41],"at":[43,147,212,235,241,255,325,349],"Week":[44],"(Wk)":[45],"16":[46],"(49.1%":[47],"vs":[48,84,208,216,225,238,244,258,271],"38.4%,":[49],"p<0.01),":[50],"and":[51,61,80,90,127,132,188,203,240,253,281,298,315,338,348,363],"comparable":[52,372],"safety.1,2":[53],"Pts":[54],"PsA":[56,89,110,126,202,314],"who":[57,134],"have":[58,64],"both":[59,144],"joint":[60,72,337],"skin":[62,339],"symptoms":[63,73],"a":[65,100,263,331],"higher":[66,197,228,264],"disease":[67],"burden":[68],"than":[69,266,341],"those":[70],"alone.3":[74],"This":[75],"exploratory":[76,368],"analysis":[77],"evaluated":[78],"efficacy":[79],"safety":[81,370,378],"BKZ":[83,136,207,252,260,324],"RZB":[85,139,209,254,267],"pts":[87,107,124,200,232,312,335],"concomitant":[91,192,316],"moderate-to-severe":[92],"psoriasis":[93],"(mod-sev":[94],"PSO).":[95],"Procedure/study:":[96],"was":[99,146,275,371],"24-wk":[101],"double-blinded":[102],"phase":[103],"3b":[104],"study":[105,299],"\u226518":[108],"(biologic-na\u00efve":[111],"or":[112,138],"inadequate":[113],"responders/intolerant":[114],"to":[115,155,166,172,222,302,330,353],"1":[116],"prior":[117],"TNF":[118],"inhibitor).1,2":[119],"We":[120],"report":[121],"data":[122],"mod-sev":[128,193,204,317],"PSO":[129,205],"(BSA\u226510%,":[130],"IGA\u22653,":[131],"PASI\u226512),":[133],"received":[135,182],"320mg":[137],"150mg.":[140],"Final":[141],"dose":[142,328],"arms":[145],"Wk16,":[148,156],"line":[150],"labels":[152],"(BKZ:":[153,288,294,304],"Q4W":[154],"then":[157,162],"Q8W;":[158],"RZB:":[159,290,296,306],"Wk0,":[160],"Wk4,":[161,347],"Q12W).":[163],"Outcomes":[164],"Wk24":[167,223,242,269],"(non-responder":[168],"imputation);":[169],"TEAEs":[170,287,293,303],"assessed":[171],"end":[173],"study.":[175],"Results:":[176],"Of":[177],"553":[178],"randomized":[179],"pts,":[180],"277/276":[181],"BKZ/RZB;":[183],"these,":[185],"29/277":[186],"(10.5%)":[187],"31/276":[189],"(11.2%)":[190],"had":[191],"PSO.":[194],"A":[195,227],"numerically":[196],"number":[198,229,333],"receiving":[206],"achieved":[210,233],"ACR50":[211],"Wk4":[213,236,256],"(27.6%":[214],"[BKZ]":[215],"9.7%":[217],"[RZB]),":[218],"which":[219],"improved":[220],"further":[221],"(65.5%":[224],"41.9%).":[226],"BKZ-treated":[231],"PASI100":[234],"(20.7%":[237],"3.2%)":[239],"(58.6%":[243],"45.2%).":[245],"Although":[246],"ACR50+PASI100":[247],"responses":[248],"were":[249,308],"similar":[250],"between":[251,373],"(3.4%":[257],"3.2%),":[259,291],"resulted":[261],"by":[268],"(44.8%":[270],"25.8%).":[272],"\u22651":[273],"TEAE":[274],"15/29":[278],"(51.7%)":[279],"BKZ-":[280],"13/31":[282],"(41.9%)":[283],"RZB-treated":[284],"pts.":[285],"Serious":[286],"0%;":[289],"severe":[292],"3.4%;":[295,305],"0%),":[297],"discontinuations":[300],"due":[301,352],"0%)":[307],"low.":[309],"Conclusion:":[310],"PSO,":[318],"dual":[319],"inhibition":[320,360],"label":[327],"led":[329],"greater":[332],"achieving":[336],"outcomes":[340],"RZB,":[343],"as":[344,346],"rapid":[345],"Wk24,":[350],"potentially":[351],"BKZ\u2019s":[354],"more":[355],"comprehensive":[356],"inflammation":[357],"control":[358],"via":[359],"IL-23-dependent":[362],"-independent":[364],"IL-17A/F.":[365],"this":[367],"analysis,":[369],"treatments,":[374],"no":[376],"new":[377],"signals":[379],"identified":[380],"BKZ.":[382]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}